🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 160 of 200 · A–Z by INN

  1. riociguat

    ADEMPAS Bayer Australia Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    C02KX05

  2. ripretinib

    QINLOCK

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01

  3. risankizumab

    SKYRIZI AbbVie

    EMA: approved · TGA: approved · PMDA: approved

    L04AC18

  4. risankizumab-rzaa

    SKYRIZI

    INJECTION FDA: approved

  5. risdiplam

    EVRYSDI Hoffmann-La Roche

    ORAL FDA: approved · EMA: approved · TGA: approved

    M09AX10

  6. risedronate

    ACTONEL Apotex Pty Ltd

    TGA: approved

  7. risedronate sodium

    RISEDRONATE SODIUM Teva Pharma GmbH

    ORAL FDA: approved

  8. risperidone

    APO-RISPERIDONE Servier Laboratories (Aust.) Pty.

    INTRAMUSCULAR FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    N05AX08

  9. ritlecitinib

    LITFULO

    EMA: approved

    L04AF08

  10. ritlecitinib tosilate

    LITFULO

    PMDA: approved

  11. ritlecitinib tosylate

    LITFULO

    ORAL FDA: approved

  12. ritodrine hydrochloride

    RITODRINE HYDROCHLORIDE

    INJECTION FDA: approved

  13. ritonavir

    NORVIR AbbVie

    ORAL FDA: approved · EMA: approved · TGA: approved · NMPA: clinical trials

    J05AE03

  14. rituximab

    RIXIMYO Pfizer Australia Pty Ltd

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    L01FA01

  15. rituximab-abbs

    TRUXIMA

    INJECTION FDA: approved

  16. rituximab-arrx

    RIABNI

    INJECTION FDA: approved

  17. rituximab-pvvr

    RUXIENCE

    INJECTION FDA: approved

  18. rivaroxaban

    APO-RIVAROXABAN Alphapharm Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    B01AF01

  19. rivastigmine

    EXELON Novartis Pharmaceuticals

    TRANSDERMAL FDA: approved · EMA: approved · TGA: approved

    N06DA03

  20. rivastigmine tartrate

    RIVASTIGMINE TARTRATE

    ORAL FDA: approved

  21. rivoceranib

    NMPA: clinical trials

  22. rizatriptan

    RIXALT Alphapharm Pty Ltd

    TGA: approved

  23. rizatriptan benzoate

    RIZATRIPTAN BENZOATE Teva Pharma GmbH

    ORAL FDA: approved

  24. rocbrutinib

    NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources